|
|
||||||||
Ann Thorac Surg 2004;77:284-288
© 2004 The Society of Thoracic Surgeons
k, MDa
slamo
lu, MDa*
rdekç
, MDa
a Department of Cardiovascular Surgery, Atatürk Medical Research Hospital,
zmir, Turkey
b Department of Cardiovascular Surgery, Ege University Medical Faculty,
zmir, Turkey
c Department of Cardiovascular Surgery, F
rat University Medical Faculty, Elaz
, Turkey
d Department of Cardiovascular Surgery, F
rat University Medical Faculty, Elaz
, Turkey
e Department of Thoracic and Cardiovascular Surgery, Kocatepe University Medical Faculty, Afyon, Turkey
Accepted for publication July 17, 2003.
* Address reprint requests to Dr Islamoglu, Ege Üniversitesi T
p Fakültesi, Kalp ve Damar Cerrahisi Anabilim Dal
35100
zmir, Turkey
e-mail: fislamoglu{at}hotmail.com
BACKGROUND: The present study was designed to evaluate the effectiveness of intrapleural 0.25% bupivacaine delivered by intermittent infusions for post-thoracotomy pain relief.
METHODS: Forty patients undergoing elective lobectomy were randomly, but equally, placed into two groups. An intrapleural catheter was inserted under direct vision during surgery. Group I received intrapleural 40 mL of 0.25% bupivacaine, group II was administered 40 mL of saline solution as a control group. Diclofenac sodium was administered as an additional analgesic, if required. Postoperative pain was evaluated using a visual analog scale (VAS), and Prince Henry pain scale. Arterial oxygen saturation, heart rate, and systemic arterial pressures were monitored. All observations were recorded 5, 10, 15, 20, 25, and 30 minutes after the injection, and thereafter at hourly intervals through the postoperative 24 hours.
RESULTS: The mean analgesia times were 5 hours and 2 hours in group I and group II, respectively. Therefore, bupivacaine administrations were repeated every 6 hours in group I, and saline with additional analgesic were administered every 4 hours in group II. The heart rate and arterial pressures did not show a significant difference. While the additional analgesic requirement was 180 ± 10 mg/d in group II, there was no need for additional analgesic administration in the group I patients. Arterial oxygen was significantly higher in group I than in group II. Arterial carbon dioxide tension of group II was significantly higher than that of group I. While the postoperative atelectasis and pneumonia developed in four patients and one, respectively, in group II, no such complication was observed in group I.
CONCLUSIONS: The easy placement of an intrapleural catheter and better pain relief observed in the present study suggest that intermittent pleural infusion of 0.25% bupivacaine has proven to be a safe and effective method for relief of post-thoracotomy pain.
This article has been cited by other articles:
![]() |
S. Dabir, T. Parsa, B. Radpay, and M. Padyab Interpleural Morphine vs Bupivacaine for Postthoracotomy Pain Relief Asian Cardiovasc Thorac Ann, October 1, 2008; 16(5): 370 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Joshi, F. Bonnet, R. Shah, R. C. Wilkinson, F. Camu, B. Fischer, E. A. M. Neugebauer, N. Rawal, S. A. Schug, C. Simanski, et al. A Systematic Review of Randomized Trials Evaluating Regional Techniques for Postthoracotomy Analgesia Anesth. Analg., September 1, 2008; 107(3): 1026 - 1040. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.S. Pramesh, R. C. Mistry, G. H. Pantvaidya, and V. R. Ghanekar Intrapleural Bupivacine for Postthoracotomy Analgesia Ann. Thorac. Surg., May 1, 2005; 79(5): 1828 - 1829. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |